Taken together, this is consistent with a scenario where the effects of OSA-induced CIH on CVDs are mediated by only a subset of MMPs, including MMP-8 and MMP-9, and that CPAP therapy alleviates this aspect of CVD risk in the short-term by eliminating the burden of CIH. This evidence concerns the gene MMP9 and obstructive sleep apnea syndrome.